<?xml version="1.0" encoding="UTF-8"?>
<p>On another note, it was previously shown that synthetic dimyristoyl phosphatidyl glycerol (DMPG) exerted its anti-inflammatory potential by silencing TLR-signaling in lipopolysaccharide (LPS)-challenged alveolar macrophages [
 <xref rid="B146-pharmaceutics-12-00688" ref-type="bibr">146</xref>]. Moreover, a mixture of DPPC, egg-phosphatidylglycerol (PG), palmitic acid (PA) and SP-CL16(6-28) (a peptide with anti-inflammatory potential) [
 <xref rid="B147-pharmaceutics-12-00688" ref-type="bibr">147</xref>] dose-dependently limited interleukin inflammatory mediators in LPS-activated human monocytes [
 <xref rid="B148-pharmaceutics-12-00688" ref-type="bibr">148</xref>]. 
</p>
